Expression of leukemia inhibitory factor and its receptor during liver regeneration in the adult rat.
Leukemia inhibitory factor (LIF) is a polyfunctional cytokine that was discovered in the conditioned medium from Buffalo rat liver cells. In the liver, LIF is known to induce acute phase proteins in the hepatocytes. No comprehensive study has yet been performed on the physiological role of this cytokine during liver regeneration. Thus, we studied the level of expression and cellular distribution of transcripts for LIF, its receptor (LIFR), and signal transducing subunit gp13O during rat liver regeneration after both simple partial hepatectomy (PH) and the oval cell activation induced by the combination of 2-acetylaminofluorene and PH. In addition, the expression of an acute phase protein alpha1-acidglycoprotein was examined. The level of transcripts for LIF and its receptor subunits increased and remained elevated during oval cell expansion. In contrast, after PH, the transcripts were induced only transiently, showing a peak 24 hours after the operation. LIF and receptor subunits were expressed in both parenchymal and nonparenchymal fractions in the 2-acetylaminofluorene/PH model, but the level of expression was most pronounced in the nonparenchymal fraction. In situ hybridization clearly revealed a strong expression of LIF, LIFR, and gp13O in the oval cells and demonstrated only a weak expression in the parenchyma. Interestingly, transcripts of alpha1-acidglycoprotein were exclusively detected in the parenchyma. These results suggest a phenotypic difference between oval cells and hepatocytes in their signaling through gp130. We hypothesize that the LIF/LIFR gp130 system may be involved in the expansion and differentiation of the liver stem cell compartment.
Omori
N
N
Laboratory of Experimental Carcinogenesis, Division of Basic Sciences, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
Evarts
R P
RP
Omori
M
M
Hu
Z
Z
Marsden
E R
ER
Thorgeirsson
S S
SS
D000209:Acute-Phase Proteins / Q000032:analysis / Q000235:genetics; D000818:Animals; D015703:Antigens, CD / Q000032:analysis / Q000235:genetics; D001652:Bile Ducts / Q000737:chemistry / Q000166:cytology; D015152:Blotting, Northern; D002478:Cells, Cultured; D050822:Cytokine Receptor gp130; D004848:Epithelium / Q000737:chemistry; D006131:Growth Inhibitors / Q000032:analysis* / Q000235:genetics; D006498:Hepatectomy; D017403:In Situ Hybridization; D015850:Interleukin-6; D053605:Leukemia Inhibitory Factor; D008099:Liver / Q000737:chemistry* / Q000166:cytology; D008115:Liver Regeneration; D008222:Lymphokines / Q000032:analysis* / Q000235:genetics; D008297:Male; D008562:Membrane Glycoproteins / Q000032:analysis / Q000235:genetics; D009961:Orosomucoid / Q000032:analysis / Q000235:genetics; D012333:RNA, Messenger / Q000032:analysis; D051381:Rats; D011916:Rats, Inbred F344; D018121:Receptors, Cytokine / Q000032:analysis*; D015398:Signal Transduction
D000209:Acute-Phase Proteins; D015703:Antigens, CD; D006131:Growth Inhibitors; C494201:Il6st protein, rat; D015850:Interleukin-6; D053605:Leukemia Inhibitory Factor; D008222:Lymphokines; D008562:Membrane Glycoproteins; D009961:Orosomucoid; D012333:RNA, Messenger; D018121:Receptors, Cytokine; D050822:Cytokine Receptor gp130